Antibodies pose a double threat to HIV

Drug treatments for HIV infection require the long-term use of daily medication that can have toxic side effects. A pair of HIV-targeting antibodies might offer an alternative therapeutic approach. Clinical trials test the use of two antibodies as a treatment for HIV.